Cashman Christopher Michael 4
4 · MARINUS PHARMACEUTICALS INC · Filed Jan 22, 2018
Insider Transaction Report
Form 4
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
- Sale
Common stock
2018-01-18$6.28/sh−9,566$60,074→ 247,903 total
Footnotes (1)
- [F1]Represents the sale of common stock in order to satisfy tax withholding obligations upon vesting of restricted stock.